Target intelligence / Profile preview

Resolving phlegm and dampness

Molecular classification
Other
01

Overview

Resolving phlegm and dampness (Hua Tan Qu Shi) is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) focused on eliminating pathological accumulations of 'phlegm' and 'dampness,' which represent metabolic disturbances and fluid imbalances [1, 5]. It is not a single molecular target like a receptor or enzyme but a holistic clinical strategy used to treat conditions such as obesity, type 2 diabetes, and polycystic ovary syndrome (PCOS) [3, 11, 14]. Modern research demonstrates that herbal formulas acting on this principle exert multi-target effects through pathways including PPAR signaling, PI3K/Akt signaling, and the restoration of gut microbiota homeostasis [5, 10, 14]. Common therapeutic agents include Pinellia ternata and Poria cocos, which act to improve metabolic clearance and reduce systemic inflammation [4, 7, 9]. Formulas such as Wen Dan Tang and Cangfu Daotan Wan utilize these components to stabilize internal metabolism and improve endocrine function [4, 14]. While marked as 'incorrect' as a specific molecular target, this principle provides a vital conceptual framework for the study of multicomponent synergies in drug development for metabolic health [8, 12].

Other names
Hua Tan Qu ShiDampness-phlegm resolutionDrying dampness and resolving phlegmRemoving dampness and phlegm
02

Mechanism of action

The mechanism involves the synergistic regulation of multi-target metabolic pathways, including the activation of PPAR signaling, modulation of the PI3K/Akt pathway, and improvement of gut microbiota composition to enhance insulin sensitivity and lipid clearance [5, 10, 14].

03

Biological functions

Fluid regulationLipid metabolismGlucose metabolismGastrointestinal function
04

Disease associations

ObesityType 2 diabetesMetabolic syndromePolycystic ovary syndrome (PCOS)Non-alcoholic fatty liver disease (NAFLD)
05

Safety considerations

Potential for fluid depletion or Yin deficiency with excessive useHerb-drug interactions with conventional metabolic or glycemic medicationsToxicity associated with unprocessed specific herbal components such as raw Pinellia
06

Interacting drugs

Cangfu Daotan Wan

6 more in the full profile.

07

Biomarkers

Phlegm-dampness constitution (PDC)Body Mass Index (BMI)Serum lipid levelsInsulin resistance (HOMA-IR)

Beyond the preview

Go deeper on Resolving phlegm and dampness.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resolving phlegm and dampness.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call